13F Data
13F filer · CIK 1869028

DC Funds, LP

MCLEAN, VA · filing since Q2 2021 · last filing Aug 14, 2026
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Reported value
$1.3M
$-232.6K vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2021: $21.1MQ3 2021: $25.5MQ4 2021: $16.9MQ1 2022: $7.7MQ2 2022: $7.2MQ3 2022: $6.6MQ4 2022: $3.7MQ1 2023: $4.3MQ2 2023: $4.7MQ3 2023: $4.9MQ4 2023: $8.3MQ1 2024: $10.3MQ2 2024: $6.0MQ3 2024: $5.2MQ4 2024: $3.6MQ1 2025: $2.1MQ2 2025: $2.2MQ3 2025: $3.1MQ4 2025: $1.5MQ1 2026: $1.5MQ2 2026: $1.3M
Q2 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1TSCAN THERAPEUTICS INCCOM630,000$617.5K49.27%
2BARINTHUS BIOTHERAPEUTICS PLADS642,204$423.9K33.82%
3WEREWOLF THERAPEUTICS INCCOM589,102$212.0K16.92%